Abu Dhabi, United Arab Emirates. November 2025

 

VIV MEA is one of the most important trade fairs in the field of animal production. Its comprehensive approach—ranging from nutrition and genetics to health, production and food processing—makes it a strategic venue for learning about the trends that are shaping the future of the sector. For three days, the exhibition centre became a hub for knowledge, networking and the presentation of solutions that respond to the current challenges facing the industry.

 

At this edition, Vetia was represented by Ernest Sendra, International Commercial Director; Abderrahmane Ghezli, Area Manager for the Middle East and North Africa; and Carlos Chipana, Veterinary Technical Advisor & Area Manager for Latin America and Asia. The team took advantage of the fair to meet with customers, distributors and partners in the region, analysing new opportunities for expansion and strengthening strategic alliances in a key market for the company.

 

In addition to business meetings, the Vetia team was able to see first-hand the trends that will shape the MENA region market in the coming years, from advances in preventive vaccination and improved biosecurity to the growing demand for technologies that support sustainable production.

 

With its participation in this edition, Vetia Animal Health strengthens its presence in a strategic market and consolidates its commitment to animal health, offering solutions that contribute to the welfare and productivity of production animals. Attendance at VIV MEA 2025 also underscores the company’s role as a technological and scientific partner in a constantly changing global environment.

San Jose, Costa Rica. November 2025

 

Vetia Animal Health participated in the 77th Annual Brucellosis Research Conference, one of the leading international meetings dedicated to brucellosis research and control. The company had its own stand as a Platinum sponsor, reinforcing its commitment to prevention and innovation in animal health.

 

During the event, Vetia Animal Health’s technical and commercial team presented a new diagnostic test for controlling swine brucellosis, developed to improve disease detection and support more efficient management on livestock farms. This innovation is part of Vetia’s strategy to promote solutions that favour safer, more sustainable and prevention-based production.

 

Vetia’s participation also included the presentation ‘New diagnostic test for Brucella in pigs’, given by Carlos Chipana, from Vetia Internacional’s technical service. His presentation aroused great interest among the attendees, who appreciated the progress that this new methodology represents in the field of veterinary diagnostics.

 

The company’s presence at this international conference reinforces Vetia Animal Health’s role as a key partner for veterinarians, researchers and livestock farmers, and underlines its commitment to developing tools that contribute to improving the health and welfare of farm animals.

Madrid, Spain. 09 September 2024

The SPACE exhibition is an unmissable event for all livestock professionals worldwide: cattle (milk and meat), poultry, pigs, sheep, goats, rabbits and aquaculture. Vetia will be promoting its brand and its full range of products, especially reinforcing its commitment to the Bluetongue disease and highlighting its know-how with the launch of the Bluevac-3 vaccine, in response to the needs of the country’s health agencies, due to the outbreaks of serotype 3 that have occurred recently.

Vetia will also present its complete vademecum of animal health solutions. It will also highlight its ‘Preventing with Experts’ platform, a tool designed to facilitate access to the best strategies for disease prevention in animals, with the aim of raising awareness, strengthening global health, improving food safety and reducing economic and social costs.

Vetia Animal Health, as a trademark of the Zendal biotechnology group, has an extensive vademecum of biological and pharmacological products, manufactured by group companies such as CZ Vaccines, Laboratorios Maymó and Laboratorios Ovejero. This alliance allows Vetia to offer a wide range of high quality products, manufactured under strict GMP-EU regulations, which respond to the needs of the veterinary sector.

Vetia Animal Health’s mission is clear: to promote animal welfare, encourage disease prevention and ensure the responsible use of medicines. The company specialises in production animals, covering the entire animal care process, from prevention to treatment and disease control.

For more information, please contact us at: info@vetiaanimalhealth.com

Madrid, Spain. 27 June 2024

During CIPORC 2024, Vetia will be promoting its brand and its complete range of products for the pig sector. The launch will also include the presentation of its new international website, where the complete vademecum of animal health solutions will be available. It will also highlight its ‘Preventing with Experts’ platform, a tool designed to facilitate access to the best strategies for disease prevention in animals, with the aim of raising awareness, strengthening global health, improving food safety and reducing economic and social costs.

Vetia Animal Health, as a trademark of the Zendal biotechnology group, has an extensive vademecum of biological and pharmacological products, manufactured by group companies such as CZ Vaccines, Laboratorios Maymó and Laboratorios Ovejero. This alliance allows Vetia to offer a wide range of high quality products, manufactured under strict GMP-EU regulations, which respond to the needs of the veterinary sector.

Vetia Animal Health’s mission is clear: to promote animal welfare, encourage disease prevention and ensure the responsible use of medicines. The company specialises in production animals, covering the entire animal care process, from prevention to treatment and disease control.

For more information, please contact us at: info@vetiaanimalhealth.com

O Porriño, Spain. 13 June 2024

Vetia Animal Health, a leader in animal health care, will participate in the XVI European Poultry Conference (EPC 2024), organised by the Spanish Association of Poultry Science. This conference, which brings together professionals and experts from the poultry sector from all over Europe, will take place in Valencia from 24 to 28 June.

Together with its Natural Remedies partners, Vetia will be present to promote its new line of complementary feed, Natural Solutions. This natural alternative is complementary to the use of antimicrobials in animal production.

Natural Solutions is manufactured by a leading company in natural herbal supplements. Thanks to more than 50 years of experience, they have been able to combine traditional botanical-based medicine with the most advanced phytochemistry. The result is 100% natural, excipient-free formulations.

Following the acquisition of Laboratorios Maymó in 2023 by the biotech group Zendal, Vetia Animal Health has become the official marketer of all its products in Spain and, more recently, also internationally.

Thanks to this acquisition, the company strengthens its catalogue of products dedicated to poultry farming and reinforces its commitment to the sector.

For more information, please contact us at: info@vetiaanimalhealth.com

Madrid, 17 January 2024

From 5 to 9 June, Vetia Animal Health took part in the 25th National Sheep Forum, held in Valladolid and organised by Tierras Ovino and TecnoCarne. Under the heading ‘Keys to review the production model’, this edition of the Forum served to analyse current aspects of the sheep sector such as the challenge of digitalisation, new perspectives in genetic improvement and reproduction, the keys to rebreeding, health problems, the increase in production costs and the importance of sustainability, among others.

Vetia played a leading role in this event as a sponsor company and offered attendees a presentation given by the Professor of Animal Health at the University of León, Valentín Pérez, entitled ‘Effects of vaccination against paratuberculosis on the parameters produced in a flock of dairy sheep’.

In it, Pérez described the serious consequences, both in terms of production and, ultimately, economically, of a dairy sheep farm being affected by this disease, also known as Johne’s disease, caused by the bacterium Mycobacterium avium subsp. paratuberculosis, or MAP.

He pointed out the stage following the first lambing as the time when the effects of paratuberculosis can be felt, as well as the different symptoms that occur in the animals depending on the productive stage of the disease: mastitis, weight loss, diarrhoea, etc.

The professor from the University of León also defended vaccination as the most appropriate control method for sheep in terms of cost-benefit. In his speech, Pérez underlined the high effectiveness of vaccination, which significantly reduces clinical cases of paratuberculosis and, in many cases, makes them disappear.

In this regard, he took the opportunity to present the results of a study carried out on an Assaf dairy farm. In these facilities, half of the replacement animals were vaccinated with Gudair for two years, leaving the other half as a non-vaccinated control. For 8 years they monitored the number of lambs born to each animal, as well as the number of lactations, the amount of milk produced and the number of deaths. The researchers were able to observe that, after 8 years, 12 ewes from the vaccinated group were still alive, compared to only one from the unvaccinated group.

Another of the main findings of this study was the significant reduction, within the non-vaccinated group, in the number of lactations and milk production, as well as in the number of lambs.

Valentín Pérez insisted that these results show that vaccination not only reduces cases of paratuberculosis, but also exerts a positive pressure on other productive and health parameters of the herd, by reducing mortality and increasing milk production and the number of lambs obtained.

For the professor of Animal Health, these positive effects could be the consequence of a learned immune response induced by the paratuberculosis vaccine, achieving cross-protection against other diseases or processes not directly related to paratuberculosis.

Vetia Animal Health would like to congratulate the organisers for the high level of the seminars included in this edition of the National Sheep Forum.

For more information: info@vetia.es

Madrid, 17 January 2024.-

Vetia Animal Health, a subsidiary of the Zendal group, once again supported two of the main events for the national pig sector: PorciFORUM, the ninth edition of which was held on 6 and 7 March in Lleida, and the XIV ANVEPI Forum, which took place on 13 and 14 March in Mérida. The company collaborated as a sponsor in both events.

As in previous editions, the brands had spaces set aside for the commercial exhibition. Vetia Animal Health participated in both meetings with its own stand from which a large representation of its technical, sales and marketing teams were able to share with attendees information about its corporate growth and the portfolio of products that the company makes available to professionals in the pig sector.

This portfolio has been expanded following the recent integration of Maymó and Iven in Vetia Animal Health, positioning the subsidiary of the Zendal group as a benchmark company in animal health in the production animal sector.

By participating in meetings such as PorciFORUM and the ANVEPI Forum, Vetia Animal Health reinforces its position as an agile and efficient alternative to provide solutions, services and quality products that help the veterinary and livestock sector, specifically the pig sector, to improve the health and welfare of their animals and, therefore, the profitability of their farms.

For more information: info@vetia.es

Madrid, 18 March 2024.

From 4 to 7 March, Vetia Animal Health, a subsidiary of the Zendal Group, organised a series of technical seminars on reproductive management in dairy cattle aimed at veterinarians specialising in reproduction.

The seminars were held in Hoznayo (Cantabria), Villagallegos (León), Soto del Barco (Asturias), Lugo and Santiago de Compostela (A Coruña) and were attended by Santiago Pérez Wallace, a technician from the Argentinean company Syntex, which specialises in hormone products for cattle that Vetia Animal Health markets in our country.

In each of these meetings, attendees were able to enjoy the vast knowledge of Pérez Wallace in his presentation on ‘Global experience in the reproductive management of dairy cattle: What have we learned?

The reproductive specialist discussed the particularities of the cow’s reproductive physiology and its importance in establishing synchronisation strategies. ‘Ovulation and heat synchronisation protocols are still widely used as a strategy to improve reproductive performance. Any insemination protocol has to produce follicular exchange, lower progesterone and induce synchronised ovulations,’ the speaker emphasised.

Based on scientific evidence, Pérez Wallace highlighted the benefits of the use of intravaginal devices with progesterone in dairy cows, which in many cases increase reproductive efficiency and facilitate management as they are simpler protocols. He also showed how the application of these devices in heifers increases pregnancy and simplifies management.

He then explained how devices with a lower progesterone concentration (DIB 1 g) achieve the same effect as those with a higher concentration, while being more comfortable, efficient and leaving less waste after use.

Finally, he discussed the use of equine serum gonadotropin (eCG) as an alternative to be evaluated in the protocols used in dairy cows, as it improves post-insemination luteal function and increases progesterone levels, which reduces embryo losses.

After the Syntex manager, Sergio Rodríguez Pedrouzo, from Vetia’s technical service for ruminants, participated in each day with a presentation on the complete range of products for bovine reproductive management (DIB, Fixplan, Prolusyn, Serigan, Sincroceliven, Hemogen and Utersol) that form part of the company’s portfolio.

Each event was closed with a discussion session in which the professionals in attendance were able to participate, and who expressed their satisfaction with these enriching seminars.

For more information: info@vetia.es

Madrid, 14 March 2024.-

Vetia Animal Health, a subsidiary of the Zendal group, once again supported two of the main events for the national pig sector: PorciFORUM, the ninth edition of which was held on 6 and 7 March in Lleida, and the XIV ANVEPI Forum, which took place on 13 and 14 March in Mérida. The company collaborated as a sponsor in both events.

As in previous editions, the brands had spaces set aside for the commercial exhibition. Vetia Animal Health participated in both meetings with its own stand from which a large representation of its technical, sales and marketing teams were able to share with attendees information about its corporate growth and the portfolio of products that the company makes available to professionals in the pig sector.

This portfolio has been expanded following the recent integration of Maymó and Iven in Vetia Animal Health, positioning the subsidiary of the Zendal group as a benchmark company in animal health in the production animal sector.

By participating in meetings such as PorciFORUM and the ANVEPI Forum, Vetia Animal Health reinforces its position as an agile and efficient alternative to provide solutions, services and quality products that help the veterinary and livestock sector, specifically the pig sector, to improve the health and welfare of their animals and, therefore, the profitability of their farms.

For more information: info@vetia.es